作者: Choon-Kee Lee , Bart Barlogie , Nikhil Munshi , Maurizio Zangari , Athanasios Fassas
关键词:
摘要: Purpose: To improve outcome in previously treated patients (at least two cycles of standard therapy) with multiple myeloma, thalidomide was combined cytotoxic chemotherapy as induction therapy. Patients and Methods: The regimen consisted 4-days oral dexamethasone, daily thalidomide, 4 days continuous-infusion cisplatin, doxorubicin, cyclophosphamide, etoposide (DTPACE). Response to DTPACE for evaluated 236 patients. Before being DTPACE, 148 (63%) had shown progressive disease while receiving chemotherapy, 55 (23%) chromosome 13 abnormalities. Results: partial remission rate (PR) after 32%, 16% attaining a complete (CR) or near-CR (nCR; defined only immunofixation electrophoresis–positive). high lactate dehydrogenase (LDH; n = 98) showed better response than those normal LDH (n 138): PR better, 43% v 27% (P .01); CR + nCR, 25% 11% ...